PharmaFluidics

Technologiepark 82

9052 Zwijnaarde

BE

PharmaFluidics

Foundation date

29/12/2020

Sector

#Supplier & Engineering

Subsector

The absence of molecular amplification in proteomics and metabolomics means that researchers rely heavily on sensitive detection of a biomarker during analytical separation. In recent years, LC performance has been the limiting factor in such experiments as the incremental improvement of conventional columns stalls. 

Based on top-level academic research demonstrating the effects of order and disorder in particulate-based separation systems, PharmaFluidics introduces a new generation of chromatography columns. The company’s know-how is the design and manufacturing of miniaturized separation columns by silicon micromachining. The perfect order in the stationary phase leads to unique benefits in terms of performance, reproducibility and robustness.

PharmaFluidics was founded in 2010 as a spin-off from the University of Brussels (VUB).

Latest news

  • Researchers unravel complexities of Alzheimer’s disease in protein fragments and plaque diversity

    11 hours ago

  • New software from UHasselt and ZEISS shows in sharp detail how biomolecules move in cells.

    1 day ago

  • Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

    1 day ago